Prognostic Models With Competing Risks Methods and Application to Coronary Risk Prediction

被引:507
作者
Wolbers, Marcel [1 ]
Koller, Michael T. [1 ,2 ,3 ]
Witteman, Jacqueline C. M. [3 ]
Steyerberg, Ewout W. [2 ]
机构
[1] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland
[2] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[3] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
关键词
CARDIOVASCULAR RISK; SUBDISTRIBUTION; HAZARDS; DISEASE; PROBABILITIES;
D O I
10.1097/EDE.0b013e3181a39056
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Clinical decision-making often relies on a subject's absolute risk of a disease event of interest. However, in a frail population, competing risk events may preclude the occurrence of the event of interest. We review competing-risk regression models with a view toward predictive modeling. We show how measures of prognostic performance (such as calibration and discrimination) can be adapted to the competing-risks setting. An example of coronary heart disease (CHD) prediction in women aged 55-90 years in the Rotterdam study is used to illustrate the proposed methods, and to compare the Fine and Gray regression model to 2 alternative approaches: (1) a standard Cox survival model, which ignores the competing risk of non-CHD death, and (2) a cause-specific hazards model, which combines proportional hazards models for the event of interest and the competing event. The Fine and Gray model and the cause-specific hazards model perform similarly. However, the standard Cox model substantially overestimates 10-year risk of CHD; it classifies 18% of the individuals as high risk (>20%), compared with only 8% according to the Fine and Gray model. We conclude that competing risks have to be considered explicitly in frail populations such as the elderly. (Epidemiology 2009;20: 555-561)
引用
收藏
页码:555 / 561
页数:7
相关论文
共 44 条
[1]  
[Anonymous], 2008, Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
[2]   A time-dependent discrimination index for survival data [J].
Antolini, L ;
Boracchi, P ;
Biganzoli, E .
STATISTICS IN MEDICINE, 2005, 24 (24) :3927-3944
[3]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[4]   A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards [J].
Beyersmann, Jan ;
Dettenkofer, Markus ;
Bertz, Hartmut ;
Schumacher, Martin .
STATISTICS IN MEDICINE, 2007, 26 (30) :5360-5369
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]   Quantification of the completeness of follow-up [J].
Clark, TG ;
Altman, DG ;
De Stavola, BL .
LANCET, 2002, 359 (9314) :1309-1310
[7]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[8]   Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve [J].
Cook, Nancy R. .
CLINICAL CHEMISTRY, 2008, 54 (01) :17-23
[9]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[10]   European guidelines on cardiovascular disease prevention in clinical practice -: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) (vol 171, pg 145, 2003) [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
ATHEROSCLEROSIS, 2004, 173 (02) :379-391